Press Release

Medical Nutrition Market to Grow with a CAGR of 7.72% through 2028

The influence of e-commerce, continuous innovation, and global expansion are expected to drive the Global Medical Nutrition Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Medical Nutrition Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Medical Nutrition Market stood at USD 62.20 billion in 2022 and is anticipated to grow with a CAGR of 7.72% in the forecast period, 2024-2028. This can be attributed to regulatory framework and quality standards. Stringent regulations and quality standards set by regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), ensure the safety and efficacy of medical nutrition products. Compliance with these standards is paramount for manufacturers, instilling confidence in consumers and healthcare professionals regarding the quality of these products.

Moreover, continuous research and innovation have led to the development of advanced ingredients for medical nutrition products. These include specialized nutrients, probiotics, prebiotics, and bioactive compounds. These innovations enhance the nutritional profiles of products and contribute to better health outcomes.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Medical Nutrition Market.”

 

The clinical nutrition market was significantly impacted by the COVID-19 pandemic, with various studies shedding light on its consequences. For instance, in a research study published in the National Library of Medicine in May 2021, it was reported that the prevalence of malnutrition among COVID-19 hospitalized patients was as high as 42%. This high prevalence underscores the insufficient nutritional support during the pandemic. Additionally, initiatives like the issuance of new guidelines are anticipated to contribute to market growth in the forecast period. As an example, in January 2021, the European Society for Clinical Nutrition and Metabolism issued guidelines related to the nutritional management of COVID-19-infected ICU patients, emphasizing the vital role of clinical nutrition in infection prevention and the treatment of infection-related malnutrition. Similarly, in February 2021, Tata & Lyle launched the Tata & Lyle Nutrition Centre, a digital platform offering authoritative scientific information on ingredients to assist food manufacturers in addressing public health challenges. Consequently, the market is expected to experience a positive impact during the study's forecast period.

Several factors are driving the growth of the clinical nutrition market, including the rising prevalence of metabolic disorders, increased healthcare expenditure, and the expansion of the middle class in emerging economies. Over the past decade, the prevalence of metabolic disorders has been on the rise. For instance, according to an article from the Gaucher's Institute updated in November 2021, Gaucher disease affects both males and females, with a worldwide prevalence of 0.70 to 1.75 per 100,000 individuals. The same source also noted that the standardized birth incidence of Gaucher disease within the general population varies from 0.39 to 5.80 per 100,000 individuals. This disease burden underscores the demand for clinical nutrition products, driving market growth. Clinical nutrition plays a significant role in minimizing adverse patient outcomes during surgeries, allowing surgeons to operate in a controlled environment. According to data from the Organization for Economic Co-operation and Development updated in August 2022, the number of surgeries performed in some European countries in 2021 included 94.87 thousand in Portugal, 49.33 thousand in Denmark, 32.84 thousand in Ireland, and 21.5 thousand in Norway. With the increasing disease burden and the volume of surgeries, the clinical nutrition market is expected to witness growth during the forecast period.

Likewise, the introduction of new products is another driver of market growth. For instance, in August 2021, Esperer Nutrition launched a range of consumer nutraceuticals targeting bone and joint health, immunity, urinary tract health, sleep apnea, and pre-diabetic care. These product launches are anticipated to boost the adoption of clinical nutrition, thereby increasing market growth in the forecast period. Consequently, the growing elderly population and the development of clinical nutrition products tailored to this demographic are expected to further stimulate market growth.

The Global Medical Nutrition Market is segmented into route of administration, application, end user, regional distribution, and company.

Based on its route of administration, it is anticipated that the Oral and Enteral Segment will maintain a significant market share throughout the projected period. Among the various methods of clinical nutrition administration, oral and enteral routes are the most frequently utilized, with parenteral administration being a less preferred alternative due to its higher associated processing costs. Physicians typically favor the oral route for its simplicity and cost-effectiveness, especially when compared to the other two administration methods.

For example, in cases of end-stage renal disease (ESRD), patients face limited treatment options, such as organ transplantation (which may not always be feasible due to donor availability issues, and even when a donor is found, the process can take several months to years) or regular hemodialysis. Specialized clinical nutrition delivered through oral and enteral feeding is prescribed to alleviate the strain on the kidneys, helping control the production of waste products like creatinine, uric acid, and bilirubin.

Based on application, Cancer is anticipated to exert a dominant influence on the Global Medical Nutrition Market throughout the forecast period for several compelling reasons. Firstly, the incidence of cancer cases continues to rise globally, making it one of the most prevalent and serious health challenges. As a result, the demand for specialized medical nutrition products that can support cancer patients during their treatment and recovery is expected to grow significantly. Additionally, advancements in medical nutrition research and innovation are yielding more effective and targeted nutritional solutions for cancer patients, further fueling market growth. Furthermore, as the aging population expands, the likelihood of cancer diagnosis increases, and this demographic trend is expected to drive the demand for medical nutrition products tailored to the specific needs of elderly cancer patients. With an array of factors converging to shape this scenario, cancer is poised to play a dominant role in shaping the dynamics of the Global Medical Nutrition Market in the coming years.

 

Major companies operating in Global Medical Nutrition Market are:

  • Abbott Nutrition Ltd
  • Nestle Health Science SA
  • Baxter Healthcare Corp
  • B Braun SE
  • Danone SA
  • Perrigo Co PLC
  • Fresenius Kabi AG
  • AYMES Nutrition
  • Reckitt Benckiser Group PLC
  • Ajinomoto Cambrooke Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global medical nutrition market is witnessing dynamic shifts and emerging trends that are shaping the future of healthcare and nutrition. Personalized nutrition, targeted disease management, sustainability, digital health, innovative ingredients, functional foods, e-commerce growth, and evolving regulatory frameworks are key factors driving the industry forward. These trends reflect the industry's commitment to providing effective and tailored nutritional solutions to meet the diverse and evolving needs of individuals seeking to manage their health through nutrition,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Medical Nutrition Market By Route of Administration (Oral and Enteral, Parenteral), By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others), By End User (Pediatric, Adult), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Medical Nutrition Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Medical Nutrition Market.

 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News